SM

Subramanian Manivannan

Active Director Director DIN 08419186
DIN 08419186 First appointment Apr 2019 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Subramanian Manivannan

Data last updated:

Subramanian Manivannan is a Director at Zentum Pharmaceuticals Private Limited (since 2019). The company operates in Trading. Zentum Pharmaceuticals Private Limited reported revenue of ₹95.1 Lakh (FY 2024).

DIN 08419186
Primary Designation Director
Industry Trading
First Appointment 11 Apr 2019
Oldest Company Age 7 yrs
Largest company Zentum Pharmaceuticals Private Limited · ₹95.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Apr 20192019₹95.1 Lakh (FY 2024)Active

Board colleagues of Subramanian Manivannan

NameDINCompanyDesignation
Mangalaraj08419185Zentum Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zentum Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Subramanian Manivannan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subramanian Manivannan

Subramanian Manivannan currently holds 1 directorship: Zentum Pharmaceuticals Private Limited (Director, since 11 Apr 2019, revenue ₹95.1 Lakh (FY 2024)).

Subramanian Manivannan was first appointed on 11 Apr 2019 as Director at Zentum Pharmaceuticals Private Limited.

The current boards of Subramanian Manivannan's companies include Mangalaraj (Zentum Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available